A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia ...

For men battling years-long addictions, a medication-assisted treatment program offers therapy and peer support. Early data ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Detailed price information for Ww International Inc (WW-Q) from The Globe and Mail including charting and trades.

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

Researchers have looked into several high-tech methods to ensure that people stay on track with their medications, like smart ...

Q. I would like to know more about the use of testosterone replacement in men. My understanding is that a recent large-scale ...

A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...